Brio Blogs

Briotech Presents Prion Research at the US FDA
By special request of the US Food and Drug Administration, Briotech is invited to present its research supporting prion inactivation with use of BrioHOCl™ at the FDA Silver Springs, MD location.

United States Food and Drug Administration
February 06, 2018

High Level Inactivation of Prions and Other Infectious Pathogens with Novel Preparations of (BrioHOCl™) Hypohalous Acids

Empty content. Please select category to preview